X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Orchid Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ORCHID PHARMA LTD - Comparison Results

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS ORCHID PHARMA LTD DR. DATSONS LABS/
ORCHID PHARMA LTD
 
P/E (TTM) x -10.9 -0.2 - View Chart
P/BV x 0.2 0.2 103.2% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DR. DATSONS LABS   ORCHID PHARMA LTD
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ORCHID PHARMA LTD
Sep-13
DR. DATSONS LABS/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs126194 64.7%   
Low Rs3135 88.3%   
Sales per share (Unadj.) Rs133.0276.5 48.1%  
Earnings per share (Unadj.) Rs0.2-79.2 -0.2%  
Cash flow per share (Unadj.) Rs6.6-43.5 -15.2%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.853.9 238.8%  
Shares outstanding (eoy) m31.6670.45 44.9%   
Bonus/Rights/Conversions FCCBESOP-  
Price / Sales ratio x0.60.4 142.1%   
Avg P/E ratio x516.1-1.4 -35,704.7%  
P/CF ratio (eoy) x11.8-2.6 -449.4%  
Price / Book Value ratio x0.62.1 28.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,4778,067 30.7%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m562,527 2.2%   
Avg. sales/employee Rs ThNM6,956.1-  
Avg. wages/employee Rs ThNM902.5-  
Avg. net profit/employee Rs ThNM-1,993.0-  
INCOME DATA
Net Sales Rs m4,21119,477 21.6%  
Other income Rs m79407 19.3%   
Total revenues Rs m4,28919,884 21.6%   
Gross profit Rs m5691,103 51.6%  
Depreciation Rs m2042,519 8.1%   
Interest Rs m4305,227 8.2%   
Profit before tax Rs m13-6,236 -0.2%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m6-125 -4.9%   
Profit after tax Rs m5-5,580 -0.1%  
Gross profit margin %13.55.7 238.5%  
Effective tax rate %48.02.0 2,392.4%   
Net profit margin %0.1-28.7 -0.4%  
BALANCE SHEET DATA
Current assets Rs m6,85211,014 62.2%   
Current liabilities Rs m6,71132,060 20.9%   
Net working cap to sales %3.3-108.1 -3.1%  
Current ratio x1.00.3 297.2%  
Inventory Days Days16195 169.5%  
Debtors Days Days31834 949.1%  
Net fixed assets Rs m3,67329,440 12.5%   
Share capital Rs m317705 44.9%   
"Free" reserves Rs m3,7612,043 184.1%   
Net worth Rs m4,0783,800 107.3%   
Long term debt Rs m1,6719,018 18.5%   
Total assets Rs m12,63346,510 27.2%  
Interest coverage x1.0-0.2 -533.1%   
Debt to equity ratio x0.42.4 17.3%  
Sales to assets ratio x0.30.4 79.6%   
Return on assets %3.4-0.8 -453.1%  
Return on equity %0.1-146.9 -0.1%  
Return on capital %7.7-3.7 -205.5%  
Exports to sales %22.937.9 60.4%   
Imports to sales %14.322.6 63.2%   
Exports (fob) Rs m9647,378 13.1%   
Imports (cif) Rs m6024,406 13.7%   
Fx inflow Rs m9647,513 12.8%   
Fx outflow Rs m6075,649 10.7%   
Net fx Rs m3571,865 19.1%   
CASH FLOW
From Operations Rs m1,3451,682 80.0%  
From Investments Rs m-2,256-9,860 22.9%  
From Financial Activity Rs m-1,2006,644 -18.1%  
Net Cashflow Rs m-2,111-1,535 137.5%  

Share Holding

Indian Promoters % 4.5 32.3 14.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 4.6 -  
FIIs % 1.4 3.3 40.9%  
ADR/GDR % 0.0 4.6 -  
Free float % 94.1 55.3 170.2%  
Shareholders   20,807 84,811 24.5%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   ALEMBIC LTD  SUN PHARMA  PFIZER  FDC LTD.  AUROBINDO PHARMA  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Open Flat; Pharma Stocks Gain(09:30 am)

Asian share markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.5% while the Hang Seng is up 1%.

Related Views on News

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Oh Yes! This is the Best Trading Opportunity in Two Decades(Profit Hunter)

Sep 21, 2018

Getting ready to buy stocks once this correction is over? This private sector bank should be on a profit hunter's radar.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

How IL&FS Rating Downgrade Will Impact Your Mutual Funds...(Outside View)

Sep 17, 2018

PersonalFN explains the impact of IL&FS rating downgrade on mutual funds.

How To Identify Sachin Tendulkars And Rahul Dravids Of Tomorrow For Your Mutual Fund Portfolio(Outside View)

Sep 19, 2018

PersonalFN explains how to pick 'undiscovered' or lesser-known mutual funds that are capable of generating big gains for you.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - LUPIN LTD COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS